Advertisement

Index by author

April 01, 1985; Volume 233,Issue 1

A

  1. Agrawal, D K

    1. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
      D K Agrawal and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 195-203;

  2. Ahmed, A E

    1. Potentiation of the hepatotoxic effect of acetaminophen by prior administration of salicylate.
      S M Douidar, P J Boor and A E Ahmed
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 242-248;

  3. Anderson, S A

    1. Mechanisms of the synergistic combination of metolazone and bumetanide.
      D C Brater, R H Pressley and S A Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 70-74;

  4. Archer, S L

    1. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
      S L Archer, R D Yankovich, E Chesler and E K Weir
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 12-17;

B

  1. Baines-Hunter, J

    1. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
      W C Elliott, D C Houghton, D N Gilbert, J Baines-Hunter and W M Bennett
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 264-270;

  2. Beach, C A

    1. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
      C A Beach, D C Mays, B M Sterman and N Gerber
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 18-23;

  3. Bell, L E

    1. Effect of halothane-oxygen anesthesia on the pharmacokinetics of diazepam and its metabolites in rats.
      L E Bell, J T Slattery and D F Calkins
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 94-99;

  4. Bennett, W M

    1. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
      W C Elliott, D C Houghton, D N Gilbert, J Baines-Hunter and W M Bennett
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 264-270;

  5. Benowitz, N L

    1. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
      S M Pond, M J Kreek, T G Tong, J Raghunath and N L Benowitz
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 1-6;

  6. Benveniste, J

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

  7. Bird, J E

    1. Renal tubular excretory transport of oxalate in the chicken.
      L M Tremaine, J E Bird and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 7-11;

  8. Blaha, C D

    1. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
      S Howard-Butcher, C D Blaha and R F Lane
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 58-63;

  9. Boor, P J

    1. Potentiation of the hepatotoxic effect of acetaminophen by prior administration of salicylate.
      S M Douidar, P J Boor and A E Ahmed
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 242-248;

  10. Boullet, C

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

  11. Boyd, L M

    1. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
      D Ezra, L M Boyd, R E Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 229-234;

  12. Brater, D C

    1. Mechanisms of the synergistic combination of metolazone and bumetanide.
      D C Brater, R H Pressley and S A Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 70-74;

  13. Brink, C

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

C

  1. Calkins, D F

    1. Effect of halothane-oxygen anesthesia on the pharmacokinetics of diazepam and its metabolites in rats.
      L E Bell, J T Slattery and D F Calkins
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 94-99;

  2. Cannon, J G

    1. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
      J C Koons, J P Long, D L Koble, J G Cannon and L J Fischer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 51-57;

  3. Cerrina, J

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

  4. Chesler, E

    1. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
      S L Archer, R D Yankovich, E Chesler and E K Weir
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 12-17;

  5. Cohen, M L

    1. Relationship between serotonin and tryptamine receptors in the rat stomach fundus.
      M L Cohen and L A Wittenauer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 75-79;

  6. Cook, P G

    1. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
      R G Pendleton, P G Cook, A Shepherd-Rose and A W Mangel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 64-69;

  7. Cooper, C L

    1. Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked to activation of alpha-1 adrenergic receptors in the isolated rat kidney.
      C L Cooper and K U Malik
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 24-31;

D

  1. Daniel, E E

    1. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
      D K Agrawal and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 195-203;

  2. Dickinson, R G

    1. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
      R G Dickinson, R M Kluck, M J Eadie and W D Hooper
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 214-221;

  3. Domino, E F

    1. Evidence for a central site of action for the antitussive effects of caramiphen.
      E F Domino, H Krutak-Krol and J Lal
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 249-253;

  4. Douidar, S M

    1. Potentiation of the hepatotoxic effect of acetaminophen by prior administration of salicylate.
      S M Douidar, P J Boor and A E Ahmed
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 242-248;

E

  1. Eadie, M J

    1. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
      R G Dickinson, R M Kluck, M J Eadie and W D Hooper
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 214-221;

  2. El-Fakahany, E E

    1. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function.
      P Feigenbaum and E E El-Fakahany
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 134-140;

  3. Elliott, W C

    1. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
      W C Elliott, D C Houghton, D N Gilbert, J Baines-Hunter and W M Bennett
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 264-270;

  4. Ezra, D

    1. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
      D Ezra, L M Boyd, R E Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 229-234;

F

  1. Feigenbaum, P

    1. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function.
      P Feigenbaum and E E El-Fakahany
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 134-140;

  2. Feuerstein, G

    1. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
      D Ezra, L M Boyd, R E Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 229-234;

  3. Fischer, L J

    1. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
      J C Koons, J P Long, D L Koble, J G Cannon and L J Fischer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 51-57;

  4. Fleisch, J H

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

  5. Fluharty, S J

    1. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
      J G Granneman, R G MacKenzie, S J Fluharty, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 163-167;
    2. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress.
      S J Fluharty, G L Snyder, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 32-38;

  6. Frossard, N

    1. Physiological approach of beta receptor coupling to adenylate cyclase in rat airways: ontogenical modification and functional antagonism.
      N Frossard and Y Landry
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 168-175;

G

  1. Garland, C J

    1. Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine.
      C J Garland
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 158-162;

  2. Gerber, N

    1. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
      C A Beach, D C Mays, B M Sterman and N Gerber
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 18-23;

  3. Gilbert, D N

    1. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
      W C Elliott, D C Houghton, D N Gilbert, J Baines-Hunter and W M Bennett
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 264-270;

  4. Goldberg, L I

    1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
      H Itoh, J D Kohli, S I Rajfer and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 87-93;

  5. Goldstein, R E

    1. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
      D Ezra, L M Boyd, R E Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 229-234;

  6. Goodson, T

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

  7. Granneman, J G

    1. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
      J G Granneman, R G MacKenzie, S J Fluharty, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 163-167;

  8. Greenamyre, J T

    1. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
      J T Greenamyre, J M Olson, J B Penney and A B Young
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 254-263;

H

  1. Haisch, K D

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

  2. Hester, R K

    1. Effects of 2-nicotinamidoethyl nitrate on agonist-sensitive Ca++ release and Ca++ entry in rabbit aorta.
      R K Hester
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 100-111;

  3. Ho, P P

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

  4. Holtzman, S G

    1. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
      S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 80-86;

  5. Hooper, W D

    1. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
      R G Dickinson, R M Kluck, M J Eadie and W D Hooper
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 214-221;

  6. Hori, R

    1. H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system.
      K Inui, M Takano, T Okano and R Hori
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 181-185;

  7. Horwitz, J

    1. Muscarine stimulates the hydrolysis of inositol-containing phospholipids in the superior cervical ganglion.
      J Horwitz, S Tsymbalov and R L Perlman
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 235-241;

  8. Houghton, D C

    1. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.
      W C Elliott, D C Houghton, D N Gilbert, J Baines-Hunter and W M Bennett
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 264-270;

  9. Howard-Butcher, S

    1. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
      S Howard-Butcher, C D Blaha and R F Lane
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 58-63;

I

  1. Inomata, H

    1. Actions of Ba++ on ionic currents of the guinea-pig taenia coli.
      H Inomata and C Y Kao
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 112-124;

  2. Inui, K

    1. H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system.
      K Inui, M Takano, T Okano and R Hori
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 181-185;

  3. Itoh, H

    1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
      H Itoh, J D Kohli, S I Rajfer and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 87-93;

K

  1. Kamataki, T

    1. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  2. Kao, C Y

    1. Actions of Ba++ on ionic currents of the guinea-pig taenia coli.
      H Inomata and C Y Kao
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 112-124;

  3. Kato, R

    1. Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP.
      S Yamamoto, T Nakadate, H Uzumaki and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 176-180;
    2. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  4. Kitani, K

    1. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  5. Kluck, R M

    1. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
      R G Dickinson, R M Kluck, M J Eadie and W D Hooper
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 214-221;

  6. Koble, D L

    1. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
      J C Koons, J P Long, D L Koble, J G Cannon and L J Fischer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 51-57;

  7. Kohli, J D

    1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
      H Itoh, J D Kohli, S I Rajfer and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 87-93;

  8. Koons, J C

    1. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
      J C Koons, J P Long, D L Koble, J G Cannon and L J Fischer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 51-57;

  9. Kreek, M J

    1. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
      S M Pond, M J Kreek, T G Tong, J Raghunath and N L Benowitz
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 1-6;

  10. Krutak-Krol, H

    1. Evidence for a central site of action for the antitussive effects of caramiphen.
      E F Domino, H Krutak-Krol and J Lal
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 249-253;

L

  1. Labat, C

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

  2. Lal, J

    1. Evidence for a central site of action for the antitussive effects of caramiphen.
      E F Domino, H Krutak-Krol and J Lal
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 249-253;

  3. Landry, Y

    1. Physiological approach of beta receptor coupling to adenylate cyclase in rat airways: ontogenical modification and functional antagonism.
      N Frossard and Y Landry
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 168-175;

  4. Lane, R F

    1. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
      S Howard-Butcher, C D Blaha and R F Lane
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 58-63;

  5. Long, J P

    1. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
      J C Koons, J P Long, D L Koble, J G Cannon and L J Fischer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 51-57;

  6. Löscher, W

    1. Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil.
      W Löscher
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 204-213;

M

  1. MacKenzie, R G

    1. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
      J G Granneman, R G MacKenzie, S J Fluharty, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 163-167;

  2. Maeda, K

    1. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  3. Malik, K U

    1. Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked to activation of alpha-1 adrenergic receptors in the isolated rat kidney.
      C L Cooper and K U Malik
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 24-31;

  4. Mangel, A W

    1. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
      R G Pendleton, P G Cook, A Shepherd-Rose and A W Mangel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 64-69;

  5. Marshall, W S

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

  6. Mays, D C

    1. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
      C A Beach, D C Mays, B M Sterman and N Gerber
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 18-23;

  7. Montgomery, M R

    1. Chlorphentermine-induced biochemical alterations in mitochondrial membranes.
      L Zychlinski and M R Montgomery
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 39-44;

  8. Morris, G

    1. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat.
      G Morris and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 141-147;

N

  1. Nagai, T

    1. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  2. Nakadate, T

    1. Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP.
      S Yamamoto, T Nakadate, H Uzumaki and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 176-180;

O

  1. Okano, T

    1. H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system.
      K Inui, M Takano, T Okano and R Hori
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 181-185;

  2. Olson, J M

    1. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
      J T Greenamyre, J M Olson, J B Penney and A B Young
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 254-263;

P

  1. Pendleton, R G

    1. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
      R G Pendleton, P G Cook, A Shepherd-Rose and A W Mangel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 64-69;

  2. Penney, J B

    1. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
      J T Greenamyre, J M Olson, J B Penney and A B Young
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 254-263;

  3. Perlman, R L

    1. Muscarine stimulates the hydrolysis of inositol-containing phospholipids in the superior cervical ganglion.
      J Horwitz, S Tsymbalov and R L Perlman
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 235-241;

  4. Pond, S M

    1. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
      S M Pond, M J Kreek, T G Tong, J Raghunath and N L Benowitz
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 1-6;

  5. Pressley, R H

    1. Mechanisms of the synergistic combination of metolazone and bumetanide.
      D C Brater, R H Pressley and S A Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 70-74;

Q

  1. Quebbemann, A J

    1. Renal tubular excretory transport of oxalate in the chicken.
      L M Tremaine, J E Bird and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 7-11;

R

  1. Raffestin, B

    1. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.
      B Raffestin, J Cerrina, C Boullet, C Labat, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 186-194;

  2. Raghunath, J

    1. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
      S M Pond, M J Kreek, T G Tong, J Raghunath and N L Benowitz
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 1-6;

  3. Rajfer, S I

    1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
      H Itoh, J D Kohli, S I Rajfer and L I Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 87-93;

  4. Richter, J A

    1. Effects of pentobarbital on t-[35S]butylbicyclophosphorothionate and [3H]flunitrazepam binding to membrane-bound and solubilized preparations from rat forebrain.
      J A Richter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 125-133;

  5. Rinkema, L E

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

S

  1. Shepherd-Rose, A

    1. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
      R G Pendleton, P G Cook, A Shepherd-Rose and A W Mangel
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 64-69;

  2. Shimada, M

    1. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.
      T Kamataki, K Maeda, M Shimada, K Kitani, T Nagai and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 222-228;

  3. Silbajoris, R A

    1. Type II cell response to chronic beta adrenergic agonist and antagonist infusions.
      S L Young and R A Silbajoris
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 271-276;

  4. Slattery, J T

    1. Effect of halothane-oxygen anesthesia on the pharmacokinetics of diazepam and its metabolites in rats.
      L E Bell, J T Slattery and D F Calkins
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 94-99;

  5. Slotkin, T A

    1. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat.
      G Morris and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 141-147;

  6. Snyder, G L

    1. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress.
      S J Fluharty, G L Snyder, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 32-38;

  7. Sterman, B M

    1. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
      C A Beach, D C Mays, B M Sterman and N Gerber
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 18-23;

  8. Stricker, E M

    1. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
      J G Granneman, R G MacKenzie, S J Fluharty, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 163-167;
    2. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress.
      S J Fluharty, G L Snyder, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 32-38;

  9. Swanson-Bean, D

    1. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
      J H Fleisch, L E Rinkema, K D Haisch, D Swanson-Bean, T Goodson, P P Ho and W S Marshall
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 148-157;

T

  1. Takano, M

    1. H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system.
      K Inui, M Takano, T Okano and R Hori
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 181-185;

  2. Tong, T G

    1. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
      S M Pond, M J Kreek, T G Tong, J Raghunath and N L Benowitz
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 1-6;

  3. Tremaine, L M

    1. Renal tubular excretory transport of oxalate in the chicken.
      L M Tremaine, J E Bird and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 7-11;

  4. Tsymbalov, S

    1. Muscarine stimulates the hydrolysis of inositol-containing phospholipids in the superior cervical ganglion.
      J Horwitz, S Tsymbalov and R L Perlman
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 235-241;

U

  1. Uzumaki, H

    1. Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP.
      S Yamamoto, T Nakadate, H Uzumaki and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 176-180;

W

  1. Weir, E K

    1. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
      S L Archer, R D Yankovich, E Chesler and E K Weir
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 12-17;

  2. Winters, W D

    1. Effects of 6-methoxy-2-benzoxazolinone on the pineal melatonin generating system.
      A Yuwiler and W D Winters
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 45-50;

  3. Wittenauer, L A

    1. Relationship between serotonin and tryptamine receptors in the rat stomach fundus.
      M L Cohen and L A Wittenauer
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 75-79;

Y

  1. Yamamoto, S

    1. Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP.
      S Yamamoto, T Nakadate, H Uzumaki and R Kato
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 176-180;

  2. Yamamura, H I

    1. Effects of pentobarbital on t-[35S]butylbicyclophosphorothionate and [3H]flunitrazepam binding to membrane-bound and solubilized preparations from rat forebrain.
      J A Richter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 125-133;

  3. Yankovich, R D

    1. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
      S L Archer, R D Yankovich, E Chesler and E K Weir
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 12-17;

  4. Young, A B

    1. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.
      J T Greenamyre, J M Olson, J B Penney and A B Young
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 254-263;

  5. Young, S L

    1. Type II cell response to chronic beta adrenergic agonist and antagonist infusions.
      S L Young and R A Silbajoris
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 271-276;

  6. Yuwiler, A

    1. Effects of 6-methoxy-2-benzoxazolinone on the pineal melatonin generating system.
      A Yuwiler and W D Winters
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 45-50;

Z

  1. Zigmond, M J

    1. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
      J G Granneman, R G MacKenzie, S J Fluharty, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 163-167;
    2. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress.
      S J Fluharty, G L Snyder, M J Zigmond and E M Stricker
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 32-38;

  2. Zychlinski, L

    1. Chlorphentermine-induced biochemical alterations in mitochondrial membranes.
      L Zychlinski and M R Montgomery
      Journal of Pharmacology and Experimental Therapeutics April 1985, 233 (1) 39-44;
Back to top

In this issue

Advertisement